Skip to main content
logo
Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.150
+0.040 (3.60%)
Oct 2, 2026, 12:55 PM EDT - Market open

Dermata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5632514
Market Cap Growth
35.19%124.01%27.62%-56.38%-65.85%-
Enterprise Value
02-3-4-32
Last Close Price
1.112.3213.5091.50981.604176.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.280.991.770.340.821.43
P/TBV Ratio
1.350.991.770.340.821.43

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.26-1.21-2.02-1.17-1.04-1.07
Net Debt / EBITDA Ratio
-----1.37
Quick Ratio
2.414.591.604.586.787.12
Current Ratio
2.814.791.794.917.537.66
Return on Equity (ROE)
-183.89%-194.20%-310.44%-125.96%-119.18%-228.09%
Return on Assets (ROA)
-89.88%-85.25%-135.86%-67.36%-65.13%-80.31%
Return on Capital Employed (ROCE)
-246.60%-124.90%-801.60%-126.50%-160.70%-77.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-181.00%-122.48%-446.00%-361.07%-194.19%-54.53%
Buyback Yield / Dilution
-391.13%-505.46%-684.76%---
SEC Filings: 10-K · 10-Q